Search

everythinglearnresearchcommunity

for

Search:↓

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Finasteride and tamsulosin hydrochloride can be safely taken together without significant interaction.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.